EMA — authorised 12 February 2007
- Marketing authorisation holder: Janssen-Cilag International NV
- Status: approved
🇪🇺 Prezista in European Union
EMA authorised Prezista on 12 February 2007
Marketing authorisation
Prezista in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Prezista approved in European Union?
Yes. EMA authorised it on 12 February 2007.
Who is the marketing authorisation holder for Prezista in European Union?
Janssen-Cilag International NV holds the EU marketing authorisation.